BioCentury
ARTICLE | Company News

Anthra, Medeva Pharmaceuticals Inc. sales and marketing update

February 8, 1999 8:00 AM UTC

Medeva began U.S. sales of Anthra's Valstar valrubicin to treat carcinoma in situ of the bladder in patients refractory to Bacillus Calmette-Guerin and who are contraindicated to receive cystectomies...